Massachusetts OKs drug marketing bill

The Massachusetts legislature passed a bill to restrict drug marketing; while it doesn't include the controversial ban on gifts to doctors, it does require disclosure of payments greater than $50 and orders the establishment of regulations that would use the industry's proposed marketing code as a springboard. Report

Suggested Articles

Mylan and Pfizer's Upjohn have a name for their pending merger: Viatris. Heard that before? So has Mylan, which owns a subsidiary with the same name.

Intercept presented a data analysis that found treatment with Ocaliva led to "early and consistent improvements" in a range of noninvasive tests.

Days before Amarin faces a pivotal FDA vote on its Vascepa expansion, advisors are set to scrutinize the placebo used in its pivotal outcomes trial.